These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 17464676

  • 1. What do dopamine transporter and catechol-o-methyltransferase tell us about attention deficit-hyperactivity disorder? Pharmacogenomic implications.
    Levy F.
    Aust N Z J Psychiatry; 2007 Jan; 41(1):10-6. PubMed ID: 17464676
    [Abstract] [Full Text] [Related]

  • 2. Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder.
    Cheon KA, Jun JY, Cho DY.
    Int Clin Psychopharmacol; 2008 Sep; 23(5):291-8. PubMed ID: 18703939
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype.
    Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, Nemanov L, Ebstein RP.
    Am J Med Genet; 1999 Oct 15; 88(5):497-502. PubMed ID: 10490706
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Schizotypy, attention deficit hyperactivity disorder, and dopamine genes.
    Ettinger U, Joober R, DE Guzman R, O'driscoll GA.
    Psychiatry Clin Neurosci; 2006 Dec 15; 60(6):764-7. PubMed ID: 17109713
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stimulant side effects and inverted-U: implications for ADHD guidelines.
    Levy F.
    Aust N Z J Psychiatry; 2013 Mar 15; 47(3):217-21. PubMed ID: 22689336
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice.
    Huotari M, Santha M, Lucas LR, Karayiorgou M, Gogos JA, Männistö PT.
    J Pharmacol Exp Ther; 2002 Dec 15; 303(3):1309-16. PubMed ID: 12438556
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Candidate gene studies of attention-deficit/hyperactivity disorder.
    Faraone SV, Khan SA.
    J Clin Psychiatry; 2006 Dec 15; 67 Suppl 8():13-20. PubMed ID: 16961425
    [Abstract] [Full Text] [Related]

  • 16. Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice.
    Käenmäki M, Tammimäki A, Myöhänen T, Pakarinen K, Amberg C, Karayiorgou M, Gogos JA, Männistö PT.
    J Neurochem; 2010 Sep 15; 114(6):1745-55. PubMed ID: 20626558
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Association analysis between attention-deficit hyperactivity disorder and Val158Met polymorphism of catechol-O-methyltransferase gene].
    Zhang XN, Ruan LM, Le YP, Zhang Y.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug 15; 20(4):322-4. PubMed ID: 12903043
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.
    McGough JJ, McCracken JT, Loo SK, Manganiello M, Leung MC, Tietjens JR, Trinh T, Baweja S, Suddath R, Smalley SL, Hellemann G, Sugar CA.
    J Am Acad Child Adolesc Psychiatry; 2009 Dec 15; 48(12):1155-64. PubMed ID: 19858760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.